1 · Identity
The name is not enough
“Poppy,” “lotus,” and “cat’s claw” can each hide a species problem. Start with the Latin binomial and plant part before considering evidence.
Chemistry before commerce
A science-first directory for understanding naturally occurring alkaloids that appear in online supplement conversations—without pretending a marketplace listing proves identity, evidence, safety, or quality.
Commerce status: research only
This page has no affiliate links, merchant links, ranked products, prices, or verified availability claims. Product recommendations remain intentionally inactive until a current catalog, label, testing, manufacturer, claims, disclosure, legal, privacy, and tracking review is complete.
Read the site’s affiliate and editorial policy1 · Identity
“Poppy,” “lotus,” and “cat’s claw” can each hide a species problem. Start with the Latin binomial and plant part before considering evidence.
2 · Evidence
Human outcomes, traditional use, receptor mechanisms, and animal studies answer different questions. This directory never treats them as interchangeable.
3 · Product
FDA does not approve dietary supplements for safety and effectiveness before sale. Labels, testing, claims, and manufacturers require their own review. [2, 3]
Ingredient directory
Evidence labels describe the kind of research available—not a recommendation. Higher-caution entries stay visible because hiding risk would make this directory less useful.
Showing 10 of 10 entries.
Caffeine from coffee, tea, guarana, kola nut, or yerba maté—or isolated caffeine
Human: Acute alertness and performance effects are well studied in people. Evidence for weight loss or broad “metabolism” promises is much less useful and often comes from multi-ingredient products.
Traditional context: Caffeinated plants have long food and beverage histories, but that does not make concentrated extracts equivalent to tea or coffee.
Mechanistic/preclinical: Adenosine-receptor antagonism explains stimulation; tolerance, sleep timing, total daily exposure, and stimulant stacking shape the practical risk.
An isolated constituent found in barberry, goldenseal, Oregon grape, and related plants
Human: Human trials and reviews report changes in some glucose and lipid markers, but study quality and populations vary. This is not evidence that berberine replaces prescribed treatment.
Traditional context: Berberine-containing plants have histories in several medical traditions; modern isolated products are a different exposure from traditional preparations.
Mechanistic/preclinical: Multiple metabolic enzymes, transporters, and signaling pathways have been studied. The same breadth helps explain why medication interactions deserve prominent attention.
A constituent of cacao; also used as an isolated ingredient in some formulas
Human: Human exposure through cacao is familiar, but that does not establish a benefit for concentrated standalone products or multi-ingredient “energy” formulas.
Traditional context: Cacao has a long food and ceremonial history. Historical use should not be used as a dose or efficacy claim for extracts.
Mechanistic/preclinical: Theobromine is pharmacologically related to caffeine but has a different stimulant and cardiovascular profile.
Eschscholzia californica aerial parts—not Papaver somniferum
Human: Clinical evidence is too limited to make confident sleep, anxiety, pain, or withdrawal claims.
Traditional context: European herbal assessments recognize a history of traditional use, which is not the same as strong clinical proof.
Mechanistic/preclinical: Alkaloid and sedative-pathway findings are largely preclinical and do not establish an opioid-like effect in people.
Nymphaea caerulea—not sacred lotus (Nelumbo nucifera)
Human: There are no robust human trials supporting general wellness, sleep, or withdrawal uses. Published clinical literature includes a small toxicity case series rather than efficacy evidence.
Traditional context: Historical and ritual associations are often repeated online, but they do not establish modern product identity, dose, or clinical benefit.
Mechanistic/preclinical: Receptor findings and constituent chemistry are hypothesis-generating; they do not predict a reliable effect from an unverified extract.
An isolated Lycopodium alkaloid associated with Huperzia serrata
Human: Trials and reviews mostly concern dementia-related clinical contexts. Reviews flag heterogeneous, low-quality primary studies, so they do not support casual memory-enhancement claims for healthy shoppers.
Traditional context: Traditional plant use does not map cleanly onto a measured isolated compound.
Mechanistic/preclinical: Acetylcholinesterase inhibition is pharmacologically meaningful and makes cholinergic stacking a safety issue, not a reason to assume cognitive benefit.
Citrus aurantium fruit or extract
Human: Weight-loss studies are generally small, short, and frequently use multi-ingredient formulas, making benefit and safety difficult to attribute to bitter orange.
Traditional context: Traditional citrus use is not evidence for concentrated stimulant-style extracts.
Mechanistic/preclinical: Adrenergic activity raises practical questions about heart rate, blood pressure, and combination with caffeine or other stimulants.
Pausinystalia yohimbe bark or a yohimbine-standardized extract
Human: NCCIH reports very little research in people on yohimbe supplements and insufficient evidence for health uses. Product analyses have also found major yohimbine-label variability.
Traditional context: Traditional use does not resolve modern extract potency, adulteration, or medication-interaction concerns.
Mechanistic/preclinical: Adrenergic effects are consistent with anxiety, blood-pressure, heart-rate, and stimulant-stacking concerns.
Corydalis yanhusuo rhizome; species and plant part are essential
Human: Human evidence is not strong enough for confident pain, sleep, or withdrawal recommendations. A recent product analysis found large alkaloid variability and a possible enriched/adulterated sample.
Traditional context: Corydalis rhizome has traditional use in Chinese medicine; that history does not validate an unidentified powder or unusually concentrated extract.
Mechanistic/preclinical: Dopamine and other receptor findings are preclinical and should not be translated into opioid-substitution or analgesic promises.
Uncaria tomentosa or Uncaria guianensis—not similarly named herbs
Human: NCCIH finds no conclusive human evidence for a health purpose. There is no reliable human evidence supporting cat’s claw as a kratom or 7-OH withdrawal aid.
Traditional context: Amazonian traditional use is culturally important context, but it is not proof for modern disease, pain, or withdrawal claims.
Mechanistic/preclinical: Immune and inflammatory findings do not establish a clinically meaningful outcome and may matter for autoimmune or medication safety.
Affiliate-readiness gate
These are inclusion gates, not quality decorations. A future catalog entry should fail closed when identity, dose, testing, manufacturer, or positioning cannot be verified.
Require the full Latin binomial; reject common-name-only labels where plants can be confused.
Bark, rhizome, aerial parts, leaf, seed, and flower are not interchangeable.
The named marker, percentage, and actual amount per serving should all be visible.
Every active ingredient and amount should be readable before purchase.
Look for a traceable company, lot number, contact path, and manufacturing-quality information.
Prefer lot-specific identity, potency, heavy-metal, microbial, and adulterant testing from an independent laboratory.
Reject proprietary blends that hide the amount of the alkaloid source or accompanying stimulants and sedatives.
Reject vaping, smoking, “legal high,” detox, withdrawal-substitute, rapid-weight-loss, or drug-like marketing.
Also check FDA’s current health-fraud notifications, especially for sexual enhancement, weight loss, energy, pain, bodybuilding, and sleep products, where hidden ingredients are a documented concern. [14, 15]
Taxonomy check
Nitrogen-containing or “nootropic” does not automatically mean alkaloid. L-theanine is the most important correction for this shopping context. [1]
A non-protein amino acid found in tea—not an alkaloid.
Read the compound profile →An amino acid—not an alkaloid.
An amino-acid derivative and serotonin precursor—not an alkaloid.
An amino sulfonic acid—not an alkaloid.
Primary research is used where available; federal and European public-health sources support taxonomy, regulation, and safety interpretation.
Editorial reading context
A safety-first directory of naturally occurring alkaloids discussed in online supplement shopping, with evidence types, taxonomy checks, and product-screening criteria—not product endorsements. This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.
For Alkaloids on Amazon, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.
When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.